Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón (FIBHGM) is a leading Spanish non-profit research entity that manages the scientific and innovation activities of the Gregorio Marañón University General Hospital. It facilitates translational research by bridging the gap between clinical practice and laboratory science across a wide array of therapeutic areas, including oncology, cardiology, and infectious diseases. The foundation is responsible for managing hundreds of active clinical trials, ranging from Phase 1 to Phase 4, and supports numerous investigator-initiated studies. FIBHGM operates state-of-the-art facilities for advanced therapies, genomics, and biobanking, making it a critical partner for international pharmaceutical collaborations and academic research. Its mission focuses on improving patient care through the development of innovative diagnostic and therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón.